Tobias Bald

Genome-wide in vivo screen identifies novel host regulators of metastatic colonization

Edward Ryder, David J. Adams, Louise van der Weyden, 2017, Nature.

Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation.

Michael Hölzel, Jennifer Landsberg, Tobias Bald, 2014, Cancer discovery.

Differential role of cannabinoids in the pathogenesis of skin cancer.

Tobias Bald, Thomas Tüting, T. Tüting, 2015, Life sciences.